Showing results (131-140 of 1,297) with videos related to
Sort By:
Pageof 130
Annals of Diagnostic Pathology|September 21, 2010
Early-stage mycosis fungoides variants: case-based reviewJeong Hee Cho-Vega, Jaime A Tschen, Madeleine Duvic, et al.Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatmentSilvia Alberti-Violetti, Rakhshandra Talpur, Megan Schlichte, et al.Journal of the American Academy of Dermatology|October 26, 2002
Optimizing bexarotene therapy for cutaneous T-cell lymphomaRakhshandra Talpur, Staci Ward, Narin Apisarnthanarax, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic actionChunlei Zhang, Parul Hazarika, Xiao Ni, et al.Cancer|January 28, 2004
Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignanciesApostolia-Maria Tsimberidou, Francis Giles, Jorge Romaguera, et al.Cancer|January 13, 2004
Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center seriesApostolia-Maria Tsimberidou, Francis Giles, Madeleine Duvic, et al.Clinical Lymphoma, Myeloma & Leukemia|December 26, 2015
Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis FungoidesRakhshandra Talpur, Dawen Sui, Pamela Gangar, et al.Journal of Drugs in Dermatology : JDD|May 30, 2019
Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma With Topical ImiquimodShelby L. Kubicki, Katherine E. Park, Phyu P. Aung, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
Stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-cell lymphomaNatalie Kash, Harina Vin, Richard Danialan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Results from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell LymphomaMadeleine Duvic, Youn H Kim, Pier Luigi Zinzani, et al.Pageof 130